Hansa Biopharma AB (publ)

LSE:0RC7 Stock Report

Market Cap: SEK 2.5b

Hansa Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0RC7?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,849,4674.2%
Individual Insiders5,331,0427.86%
Institutions11,665,13717.2%
Hedge Funds21,404,30031.6%
General Public26,564,29539.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.3%.


Top Shareholders

Top 25 shareholders own 64.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.4%
Redmile Group, LLC
13,156,700SEK 493.4m0%2.57%
12.2%
Braidwell LP
8,247,600SEK 309.3m0%1.31%
4.01%
Theodor Jeansson
2,720,000SEK 102.0m-0.37%no data
3.25%
Hansa Biopharma
2,204,667SEK 82.7m-0.43%no data
3.18%
Nexttobe AB
2,155,379SEK 80.8m0%63.47%
3.09%
Fourth Swedish National Pension Fund (AP4)
2,094,000SEK 78.5m0%0.03%
2.83%
Thomas Olausson
1,917,000SEK 71.9m0%no data
2.81%
Avanza Fonder AB
1,906,416SEK 71.5m-1.22%0.09%
2.54%
Handelsbanken Asset Management
1,724,561SEK 64.7m96.2%0.01%
2.05%
Tredje AP-fonden
1,389,600SEK 52.1m0%0.02%
1.63%
Sphera Funds Management Ltd
1,107,000SEK 41.5m0%0.67%
1.18%
C WorldWide Asset Management Fondsmaeglerselskab A/S
799,749SEK 30.0m0%0.02%
1.07%
Max Mitteregger Kapitalforvaltning AB
725,000SEK 27.2m0%100.0%
0.98%
Heights Capital Management, Inc.
667,169SEK 25.0m0%0.44%
0.95%
Vob & T Trading AB
644,800SEK 24.2m0%no data
0.88%
William Gunnarsson
600,000SEK 22.5m0%no data
0.53%
SEB Investment Management AB
358,459SEK 13.4m0%no data
0.42%
Norges Bank Investment Management
285,729SEK 10.7m0%no data
0.29%
FCG Fonder AB
197,538SEK 7.4m0%0.08%
0.27%
Storebrand Fonder AB,
186,177SEK 7.0m0%no data
0.27%
Skandia Fonder AB
183,643SEK 6.9m0%0.01%
0.23%
State Street Global Advisors, Inc.
158,949SEK 6.0m1.58%no data
0.085%
Søren Tulstrup
57,542SEK 2.2m0%no data
0.036%
Peter Nicklin
24,500SEK 918.8k0%no data
0.035%
E. Öhman J:or Wealth Management
24,000SEK 900.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 18:16
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hansa Biopharma AB (publ) is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Christian LeeABG Sundal Collier Sponsored
Madhu KumarB. Riley Securities, Inc.